Contribution of the platelet activating factor signaling pathway to cerebral microcirculatory dysfunction during

Maria Cristina Plotkowski1, Vanessa Estato2, Sabrina Alves Santos3

  • 1Department of Microbiology, Immunology and Parasitology, State University of Rio de Janeiro, 20551-30 Rio de Janeiro, Brazil crisplot77@gmail.com.

Pathogens and Disease
|July 19, 2015
PubMed

Insights

Pseudomonas aeruginosa cytotoxin ExoU causes cerebral microvascular failure in sepsis by activating the platelet activating factor receptor (PAFR) pathway. Blocking PAFR protects against sepsis-induced brain microcirculation dysfunction.

Area of Science:

  • Microbiology
  • Neuroscience
  • Pathology

Background:

  • Sepsis can lead to organ dysfunction, including the brain.
  • Pseudomonas aeruginosa is a common pathogen in sepsis.
  • The cytotoxin ExoU is implicated in bacterial virulence.

Purpose of the Study:

  • To investigate the role of ExoU in cerebral microcirculation dysfunction during experimental pneumosepsis.
  • To determine the involvement of the platelet activating factor receptor (PAFR) pathway in ExoU-mediated effects.

Main Methods:

  • Intravital microscopy in a mouse model of pneumosepsis.
  • Infection with wild-type and mutant Pseudomonas aeruginosa strains.
  • Administration of a PAFR antagonist and use of PAFR gene-deleted mice.

Main Results:

  • ExoU-producing P. aeruginosa caused increased leukocyte rolling/adhesion, decreased capillary density, and impaired arteriolar response.
  • These effects were mediated by the PAFR pathway and reversed by PAFR antagonism.
  • PAFR gene deletion attenuated microvascular dysfunction and systemic inflammation.

Conclusions:

  • ExoU contributes to cerebral microvascular failure in sepsis.
  • The PAFR pathway is a key mediator of ExoU-induced microcirculatory dysfunction.
  • Targeting the PAFR pathway may offer therapeutic benefits in sepsis.